[Is the use of beta receptor blockers in variously strong concentrations in the treatment of glaucoma sensible?].
Beta-adrenergic blocking agents are usually administered in 2 or 3 different concentrations in the treatment of glaucoma. Arguments for varying the dose are dose-dependent decompression, the onset of symptoms similar to tachyphylaxis, and the incidence of systemic side-effects which may be influenced by modification of the dose. The present author's results, however, appear to contradict these arguments; therefore, this paper discusses whether there is any advantage to be gained by administering beta blockers in different concentrations.